Preparation method of leuprorelin impurity K

Through solid-phase polypeptide synthesis method and the oxidation step of replacing Ser4 by Cys(Me) Ser4, the addition reaction of leuprolide impurity K during the preparation process was solved, the synthesis efficiency and yield were improved, and the high-purity leupropride was achieved. Preparation of Relin Impurity K, suitable for drug quality research and industrial production.

CN119039383APending Publication Date: 2024-11-29SHENZHEN JYMED TECH
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202310620434.0
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2023-05-29
Publication Date
2024-11-29

AI Technical Summary

Technical Problem

During the preparation process, the leuprolide impurity K is sensitive to piperidine and other nucleophilic reagents, and the addition reaction produces a symmetrical configuration of N-piperidinyl-alanine structure, resulting in low synthesis efficiency and high cost. And it is difficult to achieve high purity industrial production.

Method used

The intermediate resin was prepared by solid-phase polypeptide synthesis method, and the addition reaction was avoided through the amine decomposition, oxidation, dehydration and cleavage steps, and Ser4 was replaced with Cys(Me) and oxidized into sulfoxide to obtain the target olefin structure, which improved the synthesis efficiency and Yield.

Benefits of technology

The high-purity preparation of leuprolide impurity K was achieved, with the crude product purity reaching more than 83%, the yield reaching more than 60%, and the HPLC purity reaches more than 99% after purification, which is suitable for drug quality research and industrial production.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119039383A_ABST
    Figure CN119039383A_ABST
Patent Text Reader

Abstract

The invention discloses a preparation method of a leuprorelin impurity K. The preparation method comprises the following steps: preparing intermediate resin by a solid-phase polypeptide synthesis method, performing aminolysis on the intermediate resin to obtain full-protection peptide, and oxidizing, dehydrating and cracking the full-protection peptide to obtain the leuprorelin impurity K. The purity of the leuprorelin impurity K crude product prepared through the synthesis method reaches 83% or above, the yield reaches 60% or above, the HPLC purity after purification reaches 99% or above, and the leuprorelin impurity K crude product can be used as an impurity reference substance after structure confirmation and is used for quality research of leuprorelin bulk drugs and preparations.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the technical field of polypeptide drug component synthesis, and specifically relates to a method for preparing leuprorelin impurity K. Background Art

[0002] Leuprorelin is a synthetic peptide drug based on the structure of gonadotropin-releasing hormone (GnRH). It is commonly used in China along with goserelin and triptorelin. It is commonly used to treat prostate cancer, breast cancer, endometriosis, uterine fibroids and precocious puberty, or as part of sex-changing hormone therapy.

[0003] Leuprorelin is included in the official pharmacopoeias of many countries / regions, including the United States Pharmacopoeia, the European Pharmacopoeia, the British Pharmacopoeia, the Japanese Pharmacopoeia, and the Chinese Pharmacopoeia. Among them, several impurities with clear structures, from Leuprorelin Impurity A to Leuprorelin Impurity K, are disclosed in the European Pharmacopoeia EP10.0. As far as a drug is concerned, the small amount of impurities contained in it is the most important cause of drug side effects. Therefore, the inspection of its purity is one of the important foundations for ensuring the safety and effectiveness of the drug. The content of the purity inspection varies according to the properties and characteristics of each drug, but basically involves the inspection and research of their respective "related substances". In the quality inspection of leuprorelin, leuprorelin impurities A to leuprorelin impurity K are required as reference substances to check the content of impurities. Therefore, the preparation of high-purity impurities is of great significance to the quality control of leuprorelin.

[0004] The structure of Leuprorelin impurity K is as follows:

[0005]

[0006] pGlu-His-Trp-Dha-Tyr-D-Leu-Leu-Arg-Pro-NHC 2 H 5

[0007] Unlike other impurities, leuprorelin impurity K cannot be directly synthesized through the corresponding racemic amino acids. The Dha in leuprorelin impurity K is sensitive to piperidine and other nucleophiles. After Dha is produced during the preparation process, if piperidine and other nucleophiles are present, an addition reaction will occur to obtain a symmetrical N-piperidyl-alanine structure. Piperidine and nucleophiles are commonly used reagents in polypeptide synthesis, so its preparation is technically difficult. Even if it is prepared, the yield is low and the cost is very high.

[0008] Impurity research is an important part of drug quality research and one of the key factors in drug quality assurance. In order to improve the safety of clinical drug use, it is necessary to conduct detailed research and control on drug process impurities and degradation impurities during storage. For leuprolide, leuprolide impurity K is an impurity included in the official pharmacopoeia, and its quality control of drugs is even more important. Therefore, it is urgent to develop a method for preparing leuprolide impurity K. Summary of the invention

[0009] In order to overcome the above-mentioned problems in the prior art, the present invention provides a method for preparing leuprorelin impurity K, which solves the problem that Dha in leuprorelin impurity K is sensitive to piperidine and other nucleophilic reagents, avoids the addition reaction to obtain a symmetrically configured N-piperidyl-alanine structure, improves the synthesis efficiency of leuprorelin impurity K, improves the yield, reduces the cost, and is conducive to industrial production.

[0010] To this end, the present invention adopts the following technical solutions to solve the above technical problems:

[0011] A method for preparing a leuprorelin impurity K comprises preparing an intermediate resin by solid phase peptide synthesis, performing aminolysis of the intermediate resin to obtain a fully protected peptide, and performing oxidation, dehydration and cleavage of the fully protected peptide to obtain the leuprorelin impurity K, wherein the intermediate resin is as shown in formula I,

[0012]

[0013] Wherein, R1 is hydrogen or an amino protecting group,

[0014] R2 is hydrogen or an amino protecting group,

[0015] R3 is hydrogen or a hydroxyl protecting group,

[0016] R4 is hydrogen or an amino protecting group.

[0017] In some embodiments, the resin is selected from AM resin, PAM resin, Wang resin, Rink Amide MBHA resin, Rink Amide resin.

[0018] In some embodiments, the reagent used in the aminolysis is selected from ethylamine-THF, ethylamine-dioxane, ethylamine-DCM, and ethylamine-acetonitrile.

[0019] In some embodiments, the reagent used for the aminolysis is ethylamine:THF=3:7~1:1.

[0020] In some embodiments, the aminolysis time is 18-36 hours.

[0021] In some embodiments, the oxidant used in the oxidation of the fully protected peptide is selected from NaIO 4 、Na2 IO 2 , H 2 O 2 .

[0022] In some embodiments, the fully protected peptide is prepared using NaIO4 / Dioxan-H 2 O is oxidized.

[0023] In some embodiments, the dehydrating reagent is selected from DBU / MeOH.

[0024] In some embodiments, the lysis solution used in the lysis is TFA: Tis: Mpr: H 2 O=92.5:2.5:2.5:2.5.

[0025] In some embodiments, the R1 is selected from Trt, Boc, Mtt.

[0026] Preferably, R2 is selected from Boc.

[0027] Preferably, said R3 is selected from tBu.

[0028] Preferably, R4 is selected from H, pbf, and Mts.

[0029] In some embodiments, the preparation method of the intermediate resin of formula I is: after loading the linker on the starting resin, Fmoc-Pro-OH, Fmoc-Leu-Arg (R4) -OH, Fmoc-D-Leu-OH, Fmoc-Tyr (R3) -OH, Fmoc-Cys (Me) -OH, Fmoc-Trp (R2) -OH, Fmoc-His (R1) -OH, and pGlu-OH are loaded sequentially.

[0030] Preferably, the linker is a HMBA linker.

[0031] The present invention provides a method for preparing leuprorelin impurity K, using Cys (Me) to replace Ser 4 , oxidizing the thioether structure of Cys(Me) into sulfoxide, and then dehydrating to obtain the target olefin structure. The present invention solves the problem that Dha in leuprorelin impurity K is sensitive to piperidine and other nucleophilic reagents, avoids the addition reaction to obtain a symmetrical N-piperidyl-alanine structure, improves the synthesis efficiency of leuprorelin impurity K, improves the yield, reduces the cost, and is conducive to industrial production. The crude product of leuprorelin impurity K obtained by the synthesis method of the present invention has a purity of more than 83% and a yield of more than 60%. After purification, the HPLC purity reaches more than 99%, which can be used as an impurity reference substance for quality research of leuprorelin raw materials and preparations. BRIEF DESCRIPTION OF THE DRAWINGS

[0032] Figure 1 : HPLC spectrum of the crude peptide of leuprorelin impurity K of Example 1 of the present invention.

[0033] Figure 2 : HPLC spectrum of the impurity K peptide of leuprorelin in Example 1 of the present invention.

[0034] Figure 3 : MS spectrum of leuprorelin impurity K in Example 1 of the present invention.

[0035] Figure 4 : Schematic diagram of the process of leuprorelin impurity K in Example 1 of the present invention. DETAILED DESCRIPTION

[0036] The specific implementation modes of the present invention are described in detail below in conjunction with the accompanying drawings. The described embodiments are only for illustration and explanation of the present invention and do not constitute the sole limitation of the present invention.

[0037] Example 1: Preparation of Leuprorelin Impurity K

[0038] Weigh 5.0 mmol AM resin, load HMBA linker, and then sequentially load Fmoc-Pro-OH, Fmoc-Leu-Arg(Pbf)-OH, Fmoc-D-Leu-OH, Fmoc-Tyr(OtBu)-OH, Fmoc-Cys(Me)-OH, Fmoc-Trp(Boc)-OH, Fmoc-His(Trt)-OH, and pGlu-OH. After the coupling, pGlu-His(Trt)-Trp(Boc)-Cys(Me)-Tyr(OtBu)-D-Leu-Leu-Arg(Pbf)-Pro-HMBA linker-AM resin was obtained.

[0039] The resin was aminolyzed with ethylamine-THF (1:1, v / v) for 24 h, concentrated, and precipitated with isopropyl ether, and vacuum-dried to obtain the fully protected crude peptide.

[0040] Dissolve 0.879g sodium periodate (1.1eq) in 75ml purified water, cool to 0-5°C, dissolve 7.00g fully protected crude peptide (1.0eq) in 150ml 1,4-dioxane and stir thoroughly, and carefully drop the clarified liquid into the above oxidizing solution. Keep the reaction at 0-5°C for 3 hours, concentrate to remove 1,4-dioxane, add 600ml ethyl acetate to extract the water layer twice (300ml*2), collect the organic phase, wash with purified water twice (100ml*2), wash with saturated brine twice (100ml*2), dry with anhydrous sodium sulfate for more than 2 hours, and concentrate until no condensate drops to obtain a light yellow oil.

[0041] The light yellow oil was dissolved in 100 ml of methanol and stirred to clarify, then 1.14 g of DBU was added. After reacting for 4 hours, the methanol was removed by concentration. After dissolving in 200 ml of ethyl acetate, 5% potassium hydrogen sulfate aqueous solution was added to wash twice (100 ml*2), and saturated brine was used to wash twice (100 ml*2). The oil was dried over anhydrous sodium sulfate for more than 2 hours and concentrated to obtain a light yellow solid.

[0042] The light yellow solid was washed with 80 ml of lysis buffer (TFA: Tis: Mpr: H 2 O=92.5:2.5:2.5:2.5) for 2 hours, concentrated to 50 ml, added to 500 ml of ice-cold isopropyl ether for precipitation, centrifuged to collect the solid, and dried to obtain 5.92 g of crude product. A small amount of crude product was taken for analysis, and the HPLC spectrum was as follows Figure 1 As shown, the purity is 83.30% and the yield is 63.2%.

[0043] Take the crude product of leuprorelin impurity K, dissolve it with purified water, and filter it with a whatman filter membrane after it is completely dissolved. Then purify it using a reverse phase C18 filler column ZB025. 0.1% TFA / acetonitrile is used for equilibrium replacement. After the fractions are detected, they are combined and concentrated by rotary evaporation and freeze-dried to obtain leuprorelin impurity K. The product is tested by analytical liquid HPLC and the purity is 99.01%. The HPLC spectrum is as follows Figure 2 The molecular ion peak of the sample detected in the positive ion mode of the mass spectrometry electrospray ionization source is 1191.74, which is consistent with the theoretical value of the relative molecular mass of the leuprorelin impurity K, M = 1191.41. The MS spectrum is shown in Figure 3 shown.

[0044] Example 2: Preparation of Leuprorelin Impurity K 2

[0045] Weigh 5.0 mmol of PAM resin and load Fmoc-Pro-OH, Fmoc-Leu-OH, Fmoc-Arg-OH, Fmoc-D-Leu-OH, Fmoc-Tyr(OtBu)-OH, Fmoc-Cys(Me)-OH, Fmoc-Trp(Boc)-OH, Fmoc-His(Boc)-OH, and pGlu-OH in sequence. After the coupling, pGlu-His(Boc)-Trp(Boc)-Cys(Me)-Tyr(OtBu)-D-Leu-Leu-Arg-Pro-PAM resin was obtained.

[0046] The resin was aminolyzed with ethylamine-THF (2:4, v / v) for 18 h, concentrated, and precipitated with isopropyl ether. The fully protected crude peptide was obtained by vacuum drying.

[0047] Dissolve 0.879g sodium periodate (1.1eq) in 75ml purified water, cool to 0-5°C, dissolve 7.00g fully protected crude peptide (1.0eq) in 150ml acetonitrile and stir thoroughly, and carefully drop the clarified solution into the above oxidizing solution. Keep the reaction at 0-5°C for 3 hours, concentrate to remove acetonitrile, add 600ml ethyl acetate to extract the water layer twice (300ml*2), collect the organic phase, wash with purified water twice (100ml*2), wash with saturated brine twice (100ml*2), dry with anhydrous sodium sulfate for more than 2 hours, and concentrate until no condensate drops to obtain a light yellow oil.

[0048] The light yellow oil was dissolved in 100 ml of methanol and stirred to clarify, then 1.14 g of DBU was added. After reacting for 4 hours, the methanol was removed by concentration. After dissolving in 200 ml of ethyl acetate, 5% potassium hydrogen sulfate aqueous solution was added to wash twice (100 ml*2), and saturated brine was used to wash twice (100 ml*2). The oil was dried over anhydrous sodium sulfate for more than 2 hours and concentrated to obtain a light yellow solid.

[0049] The light yellow solid was lysed with 80 ml of lysate (TFA: Tis: Mpr: H2O = 92.5: 2.5: 2.5: 2.5) for 2 hours, concentrated to 50 ml, added to 500 ml of ice-cold isopropyl ether for precipitation, centrifuged to collect the solid, and dried to obtain 5.00 g of crude product. A small amount of the crude product was taken for analysis, and the HPLC spectrum was consistent with Figure 1 The results are similar, with a purity of 83.31% and a yield of 60.5%.

[0050] Take the crude product of leuprorelin impurity K, dissolve it with purified water, and filter it with a whatman filter membrane after it is completely dissolved. Then purify it using a reverse phase C18 packed column ZB025. 0.1% TFA / acetonitrile is used for equilibrium replacement. After the fractions are detected, they are combined and concentrated by rotary evaporation and freeze-dried to obtain leuprorelin impurity K. The product is tested by analytical liquid HPLC, and the purity is 99.16%. The HPLC spectrum is consistent with Figure 2 The molecular ion peak of the sample detected in the positive ion mode of the mass spectrometry electrospray ionization source is 1191.74, which is consistent with the theoretical value of the relative molecular mass of the leuprorelin impurity K, M = 1191.41. Figure 3 similar.

[0051] Example 3: Preparation of Leuprorelin Impurity K

[0052] Weigh 5.0 mmol Wang resin and load Fmoc-Pro-OH, Fmoc-Leu-Arg(Mts)-OH, Fmoc-D-Leu-OH, Fmoc-Tyr(OtBu)-OH, Fmoc-Cys(Me)-OH, Fmoc-Trp(Boc)-OH, Fmoc-His(Mtt)-OH, pGlu-OH in sequence. After the coupling, pGlu-His(Mtt)-Trp(Boc)-Cys(Me)-Tyr(OtBu)-D-Leu-Leu-Arg(Mts)-Pro-Wang resin was obtained.

[0053] The resin was aminolyzed with ethylamine-THF (3:7, v / v) for 36 h, concentrated, and precipitated with isopropyl ether, and vacuum-dried to obtain the fully protected crude peptide.

[0054] Dissolve 0.879g Na2IO2 (1.1eq) in 75ml purified water, cool to 0-5°C, dissolve 7.00g fully protected crude peptide (1.0eq) in 150ml acetonitrile and stir thoroughly, and carefully drop the clarified solution into the above oxidizing solution. Keep the reaction at 0-5°C for 3 hours, concentrate to remove acetonitrile, add 600ml ethyl acetate to extract the water layer twice (300ml*2), collect the organic phase, wash with purified water twice (100ml*2), wash with saturated brine twice (100ml*2), dry with anhydrous sodium sulfate for more than 2 hours, and concentrate until no condensate drops to obtain a light yellow oil.

[0055] The light yellow oil was dissolved in 100 ml of methanol and stirred to clarify, then 1.14 g of DBU was added. After reacting for 4 hours, the methanol was removed by concentration. After dissolving in 200 ml of ethyl acetate, 5% potassium hydrogen sulfate aqueous solution was added to wash twice (100 ml*2), and saturated brine was used to wash twice (100 ml*2). The oil was dried over anhydrous sodium sulfate for more than 2 hours and concentrated to obtain a light yellow solid.

[0056] The light yellow solid was lysed with 80 ml of lysate (TFA: Tis: Mpr: H2O = 92.5: 2.5: 2.5: 2.5) for 2 hours, concentrated to 50 ml, added to 500 ml of ice-cold isopropyl ether for precipitation, centrifuged to collect the solid, and dried to obtain 4.52 g of crude product. A small amount of crude product was taken for analysis, and the HPLC spectrum was consistent with Figure 1 The results are similar, with a purity of 83.32% and a yield of 60.6%.

[0057] Take the crude product of leuprorelin impurity K, dissolve it with purified water, and filter it with a whatman filter membrane after it is completely dissolved. Then purify it using a reverse phase C18 packed column ZB025. 0.1% TFA / acetonitrile is used for equilibrium replacement. After the fractions are detected, they are combined and concentrated by rotary evaporation and freeze-dried to obtain leuprorelin impurity K. The product is tested by analytical liquid HPLC, and the purity is 99.31%. The HPLC spectrum is consistent with Figure 2 The molecular ion peak of the sample detected in the positive ion mode of the mass spectrometry electrospray ionization source is 1191.74, which is consistent with the theoretical value of the relative molecular mass of the leuprorelin impurity K, M = 1191.41. Figure 3 similar.

[0058] Example 4: Preparation of Leuprorelin Impurity K

[0059] Weigh 5.0 mmol of Rink Amide MBHA resin and load Fmoc-Pro-OH, Fmoc-Leu-Arg-OH, Fmoc-D-Leu-OH, Fmoc-Tyr(OtBu)-OH, Fmoc-Cys(Me)-OH, Fmoc-Trp(Boc)-OH, Fmoc-His(Trt)-OH, and pGlu-OH in sequence. After the coupling, pGlu-His(Trt)-Trp(Boc)-Cys(Me)-Tyr(OtBu)-D-Leu-Leu-Arg-Pro-Rink Amide MBHA resin was obtained.

[0060] The resin was aminolyzed with ethylamine-dioxane (3:7, v / v) for 24 h, concentrated, precipitated with isopropyl ether, and vacuum-dried to obtain the fully protected crude peptide.

[0061] Dissolve 0.879g H2O2 (1.1eq) in 75ml purified water, cool to 0-5°C, dissolve 7.00g fully protected crude peptide (1.0eq) in 150ml DMSO and stir thoroughly, and carefully drop the clear solution into the above oxidizing solution. Keep the temperature at 0-5°C for 3 hours, concentrate to remove DMSO, add 600ml ethyl acetate to extract the water layer twice (300ml*2), collect the organic phase, wash with purified water twice (100ml*2), wash with saturated brine twice (100ml*2), dry with anhydrous sodium sulfate for more than 2 hours, and concentrate until no condensate drops to obtain a light yellow oil.

[0062] The light yellow oil was dissolved in 100 ml of methanol and stirred to clarify, then 1.14 g of DBU was added. After reacting for 4 hours, the methanol was removed by concentration. After dissolving in 200 ml of ethyl acetate, 5% potassium hydrogen sulfate aqueous solution was added to wash twice (100 ml*2), and saturated brine was used to wash twice (100 ml*2). The oil was dried over anhydrous sodium sulfate for more than 2 hours and concentrated to obtain a light yellow solid.

[0063] The light yellow solid was lysed with 80 ml of lysate (TFA: Tis: Mpr: H2O = 92.5: 2.5: 2.5: 2.5) for 2 hours, concentrated to 50 ml, added to 500 ml of ice-cold isopropyl ether for precipitation, centrifuged to collect the solid, and dried to obtain 4.23 g of crude product. A small amount of crude product was taken for analysis, and the HPLC spectrum was consistent with Figure 1 The results are similar, with a purity of 83.23% and a yield of 60.3%.

[0064] Take the crude product of leuprorelin impurity K, dissolve it with purified water, and filter it with a whatman filter membrane after it is completely dissolved. Then purify it using a reverse phase C18 packed column ZB025. 0.1% TFA / acetonitrile is used for equilibrium replacement. After the fractions are detected, they are combined and concentrated by rotary evaporation and freeze-dried to obtain leuprorelin impurity K. The product is tested by analytical liquid HPLC, and the purity is 99.21%. The HPLC spectrum is consistent with Figure 2 The molecular ion peak of the sample detected in the positive ion mode of the mass spectrometry electrospray ionization source is 1191.74, which is consistent with the theoretical value of the relative molecular mass of the leuprorelin impurity K, M = 1191.41. Figure 3 similar.

[0065] Example 5: Preparation of Leuprorelin Impurity K

[0066] Weigh 5.0 mmol of Rink Amide resin and load Fmoc-Pro-OH, Fmoc-Leu-Arg(Pbf)-OH, Fmoc-D-Leu-OH, Fmoc-Tyr(OtBu)-OH, Fmoc-Cys(Me)-OH, Fmoc-Trp(Boc)-OH, Fmoc-His(Boc)-OH, and pGlu-OH in sequence. After the coupling, pGlu-His(Boc)-Trp(Boc)-Cys(Me)-Tyr(OtBu)-D-Leu-Leu-Arg(pbf)-Pro-Rink Amide resin was obtained.

[0067] The resin was aminolyzed with ethylamine-DCM (3:7, v / v) for 18 h, concentrated, and precipitated with isopropyl ether. The fully protected crude peptide was obtained by vacuum drying.

[0068] Dissolve 0.879g NaIO4 (1.1eq) in 75ml purified water, cool to 0-5°C, dissolve 7.00g fully protected crude peptide (1.0eq) in 150ml DMF and stir thoroughly, and carefully drop the clear solution into the above oxidizing solution. Keep the temperature at 0-5°C for 3 hours, concentrate to remove DMF, add 600ml ethyl acetate to extract the water layer twice (300ml*2), collect the organic phase, wash twice with purified water (100ml*2), wash twice with saturated brine (100ml*2), dry over anhydrous sodium sulfate for more than 2 hours, and concentrate until no condensate drops to obtain a light yellow oil.

[0069] The light yellow oil was dissolved in 100 ml of methanol and stirred to clarify, then 1.14 g of DBU was added. After reacting for 4 hours, the methanol was removed by concentration. After dissolving in 200 ml of ethyl acetate, 5% potassium hydrogen sulfate aqueous solution was added to wash twice (100 ml*2), and saturated brine was used to wash twice (100 ml*2). The oil was dried over anhydrous sodium sulfate for more than 2 hours and concentrated to obtain a light yellow solid.

[0070] The light yellow solid was lysed with 80 ml of lysate (TFA: Tis: Mpr: H2O = 92.5: 2.5: 2.5: 2.5) for 2 hours, concentrated to 50 ml, added to 500 ml of ice-cold isopropyl ether for precipitation, centrifuged to collect the solid, and dried to obtain 4.35 g of crude product. A small amount of crude product was taken for analysis, and the HPLC spectrum was consistent with Figure 1 The results are similar, with a purity of 83.36% and a yield of 61.5%.

[0071] Take the crude product of leuprorelin impurity K, dissolve it with purified water, and filter it with a whatman filter membrane after it is completely dissolved. Then purify it using a reverse phase C18 packed column ZB025. 0.1% TFA / acetonitrile is used for equilibrium replacement. After the fractions are detected, they are combined and concentrated by rotary evaporation and freeze-dried to obtain leuprorelin impurity K. The product is tested by analytical liquid HPLC, and the purity is 99.31%. The HPLC spectrum is consistent with Figure 2 The molecular ion peak of the sample detected in the positive ion mode of the mass spectrometry electrospray ionization source is 1191.74, which is consistent with the theoretical value of the relative molecular mass of the leuprorelin impurity K, M = 1191.41. Figure 3 similar.

[0072] Example 6: Preparation of Leuprorelin Impurity K

[0073] Weigh 5.0mmol AM resin, load HMBA linker, and then load Fmoc-Pro-OH, Fmoc-Leu-Arg(Mts)-OH, Fmoc-Tyr(OtBu)-OH, Fmoc-Cys(Me)-OH, Fmoc-Trp(Boc)-OH, Fmoc-His(Mtt)-OH, and pGlu-OH in sequence. After the coupling, pGlu-His(Mtt)-Trp(Boc)-Cys(Me)-Tyr(OtBu)-D-Leu-Leu-Arg(Mts)-Pro-AM resin was obtained.

[0074] The resin was aminolyzed with ethylamine-acetonitrile (3:7, v / v) for 36 h, concentrated, precipitated with isopropyl ether, and vacuum-dried to obtain the fully protected crude peptide.

[0075] Dissolve 0.879g H2O2 (1.1eq) in 75ml purified water, cool to 0-5°C, dissolve 7.00g fully protected crude peptide (1.0eq) in 150ml acetonitrile and stir thoroughly, and carefully drop the clear solution into the above oxidation solution. Keep the temperature at 0-5°C for 3 hours, concentrate to remove acetonitrile, add 600ml ethyl acetate to extract the water layer twice (300ml*2), collect the organic phase, wash twice with purified water (100ml*2), wash twice with saturated brine (100ml*2), dry over anhydrous sodium sulfate for more than 2 hours, and concentrate until no condensate drops to obtain a light yellow oil.

[0076] The light yellow oil was dissolved in 100 ml of methanol and stirred to clarify, then 1.14 g of DBU was added. After reacting for 4 hours, the methanol was removed by concentration. After dissolving in 200 ml of ethyl acetate, 5% potassium hydrogen sulfate aqueous solution was added to wash twice (100 ml*2), and saturated brine was used to wash twice (100 ml*2). The oil was dried over anhydrous sodium sulfate for more than 2 hours and concentrated to obtain a light yellow solid.

[0077] The light yellow solid was lysed with 80 ml of lysate (TFA: Tis: Mpr: H2O = 92.5: 2.5: 2.5: 2.5) for 2 hours, concentrated to 50 ml, added to 500 ml of ice-cold isopropyl ether for precipitation, centrifuged to collect the solid, and dried to obtain 4.12 g of crude product. A small amount of crude product was taken for analysis, and the HPLC spectrum was consistent with Figure 1 The results are similar, with a purity of 83.41% and a yield of 61.5%.

[0078] Take the crude product of leuprorelin impurity K, dissolve it with purified water, and filter it with a whatman filter membrane after it is completely dissolved. Then purify it using a reverse phase C18 packed column ZB025. 0.1% TFA / acetonitrile is used for equilibrium replacement. After the fractions are detected, they are combined and concentrated by rotary evaporation and freeze-dried to obtain leuprorelin impurity K. The product is tested by analytical liquid HPLC, and the purity is 99.24%. The HPLC spectrum is consistent with Figure 2 The molecular ion peak of the sample detected in the positive ion mode of the mass spectrometry electrospray ionization source is 1191.74, which is consistent with the theoretical value of the relative molecular mass of the leuprorelin impurity K, M = 1191.41. Figure 3 similar.

Claims

1. A method for preparing leuprorelin impurity K, characterized in that: The intermediate resin is prepared by solid phase peptide synthesis, the intermediate resin is aminolyzed to obtain a fully protected peptide, and the fully protected peptide is oxidized, dehydrated, and cleaved to obtain leuprorelin impurity K, wherein the intermediate resin is as shown in formula I, Wherein, R1 is hydrogen or an amino protecting group, R2 is hydrogen or an amino protecting group, R3 is hydrogen or a hydroxyl protecting group, R4 is hydrogen or an amino protecting group.

2. The preparation method according to claim 1, characterized in that: The resin is selected from AM resin and PAM resin, Wang resin, Rink Amide MBHA resin, Rink Amide resin.

3. The preparation method according to claim 1, characterized in that: The reagent used in the aminolysis is selected from ethylamine-THF, ethylamine-dioxane, ethylamine-DCM, and ethylamine-acetonitrile.

4. The preparation method according to claim 3, characterized in that: The reagent used in the aminolysis is ethylamine:THF=3:7-1:

1.

5. The preparation method according to any one of claims 2 to 4, characterized in that: The aminolysis time is 18-36 hours.

6. The preparation method according to claim 1, characterized in that: The oxidant used in the oxidation of the fully protected peptide is selected from NaIO4, Na2IO2, and H2O2.

7. The preparation method according to claim 6, characterized in that: The fully protected peptide was oxidized using NaIO4 / Dioxan-H2O.

8. The preparation method according to claim 1, characterized in that: The dehydrating agent is selected from DBU / MeOH.

9. The preparation method according to claim 1, characterized in that: The lysis solution used in the lysis is TFA:Tis:Mpr:H2O=92.5:2.5:2.5:2.

5.

10. The preparation method according to claim 1, characterized in that: The R1 is selected from Trt, Boc, and Mtt.

11. The preparation method according to claim 1, characterized in that: The R2 is selected from Boc.

12. The preparation method according to claim 1, characterized in that: The R3 is selected from tBu.

13. The preparation method according to claim 1, characterized in that: The R4 is selected from H, pbf, and Mts.

14. The preparation method according to claim 1, characterized in that: The preparation method of the intermediate resin of formula I is as follows: after loading the linker on the starting resin, Fmoc-Pro-OH, Fmoc-Leu-Arg (R4) -OH, Fmoc-D-Leu-OH, Fmoc-Tyr (R3) -OH, Fmoc-Cys (Me) -OH, Fmoc-Trp (R2) -OH, Fmoc-His (R1) -OH are loaded in sequence. pGlu-OH.

15. The preparation method according to claim 14, characterized in that: The linker is an HMBA linker.